Drug Profile
Ebrotidine
Alternative Names: Ebrocit; FI 3542Latest Information Update: 10 Nov 1998
Price :
$50
*
At a glance
- Originator Ferrer
- Developer Ferrer; Robert
- Class Antiulcers; Benzenesulfonates; Gastric antisecretories; Small molecules; Thiazoles
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Duodenal ulcer; Gastric ulcer
- Discontinued Reflux oesophagitis
Most Recent Events
- 10 Nov 1998 Discontinued-III for Reflux oesophagitis in Poland (PO)
- 10 Nov 1998 Withdrawn for Duodenal ulcer in Peru (PO)
- 10 Nov 1998 Withdrawn for Gastric ulcer in Peru (PO)